Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | 1 | 96867 | IM / LA |
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
None reported
High risk sexual behavior Immune to hepatitis B Major depressive disorder, recurrent severe without psychotic features Generalized anxiety disorder Encounter for pre-exposure prophylaxis for HIV Need for vaccination
emtricitabine-tenofovir alafenamide fumarate (DESCOVY) 200-25 mg tablet venlafaxine (EFFEXOR-XR) 150 mg XR capsule
NKDA
N/A